Docetaxel in Non Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Carcinoma, Squamous Cell
Interventions
DRUG

Docetaxel + CDDP

"* 3 cycles chemotherapy : docetaxel + CDDP~* Surgery (if no histologically proven R0-resection could be achieved,additional adjuvant radiotherapy should be considered)~* 3 cycles adjuvant chemotherapy docetaxel"

DRUG

docetaxel + CDDP

"* 3 cycles chemotherapy: docetaxel + CDDP~* Radiochemotherapy~* 3 cycles adjuvant chemotherapy docetaxel"

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Vienna

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY